ODEFSEY 200 mg/25 mg/25 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930061558
  • CIP7 3006155
  • CIS 64689693
  • Registration number EU/1/16/1112

What the source publishes

Holder
GILEAD SCIENCES IRELAND UC (IRLANDE)
Active ingredients
RILPIVIRINE, EMTRICITABINE, FUMARATE DE TÉNOFOVIR ALAFÉNAMIDE, CHLORHYDRATE DE RILPIVIRINE, TÉNOFOVIR ALAFÉNAMIDE
Form
comprimé pelliculé
Package
flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
2016-06-21
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930061558
{
  "cis": "64689693",
  "cip7": "3006155",
  "form": "comprimé pelliculé",
  "name": "ODEFSEY 200 mg/25 mg/25 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)",
  "cip13": "3400930061558",
  "holder": "GILEAD SCIENCES IRELAND UC (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "GILEAD SCIENCES IRELAND UC (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "436.52",
  "authorisedOn": "2016-06-21",
  "compositions": [
    {
      "name": "RILPIVIRINE",
      "nature": "FT",
      "strength": "25 mg",
      "linkageNumber": "2",
      "substanceCode": "27775",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "EMTRICITABINE",
      "nature": "SA",
      "strength": "200 mg",
      "linkageNumber": "1",
      "substanceCode": "60459",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "FUMARATE DE TÉNOFOVIR ALAFÉNAMIDE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "3",
      "substanceCode": "91140",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE RILPIVIRINE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "2",
      "substanceCode": "94011",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "TÉNOFOVIR ALAFÉNAMIDE",
      "nature": "FT",
      "strength": "25 mg",
      "linkageNumber": "3",
      "substanceCode": "98937",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "435.50",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ODEFSEY 200 mg/25 mg/25 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2018-01-15",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "RILPIVIRINE",
    "EMTRICITABINE",
    "FUMARATE DE TÉNOFOVIR ALAFÉNAMIDE",
    "CHLORHYDRATE DE RILPIVIRINE",
    "TÉNOFOVIR ALAFÉNAMIDE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription initiale hospitalière annuelle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/16/1112",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930061558"